Infection with the novel GB-C virus in multiply transfused patients and in various forms of chronic liver disease
Hadziyannis, S.J.; Dawson, G.J.; Vrettou, E.; Gioustozi, A.; Schlauder, G.; Desai, S.
Hepatology 22(4 Part 2): 218A
1995
ISSN/ISBN: 0270-9139
Accession: 031911604
PDF emailed within 1 workday: $29.90
Related References
Slavov, S.N.; Otaguiri, K.K.; Macedo, M.D.; Rocha-Júnior, M.íc.C.; Silva-Pinto, A.C.; Kashima, S.; Covas, D.T. 2014: No evidence of xenotropic murine leukemia virus-related virus infection in Brazilian multiply transfused patients with sickle cell disease and beta-thalassemia major New Microbiologica 37(4): 543-550Papaevangelou, V.; Spanou, E.; Kattamis, C.; Hadziyannis, S. 1997: GBV-C infection in multiply transfused thalassemia patients with chronic non A-E hepatitis Journal of Hepatology 26(Suppl 1): 91
Beltrán, M.; Navas, M.ía.C.; Arbeláez, M.ía.P.; Donado, J.; Jaramillo, S.; De la Hoz, F.; Estrada, C.; Cortés, L.ía.d.P.; de Maldonado, A.; Rey, G. 2009: Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia Biomedica: Revista del Instituto Nacional de Salud 29(2): 232-243
Telfer, P.T.; Whitby, K.; Garson, J.A.; Hoffbrand, A.V.; Wonke, B. 1995: Alpha interferon alone and in combination with ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients Blood 86(10 Suppl 1): 484A
Feitelson, M.A.; Taddei, M.G.; Ballas, S.K. 1996: Evidence for underlying hepatitis B virus infection among multiply transfused patients with sickle cell anemia Blood 88(10 Suppl 1 Part 1-2): 527A
Toyoda, H.; Fukuda, Y.; Nakano, I.; Katano, Y.; Yokozaki, S.; Hayashi, K.; Ito, Y.; Suzuki, K.; Nakano, H.; Saito, H.; Takamatsu, J. 2001: TT virus genotype changes frequently in multiply transfused patients with hemophilia but rarely in patients with chronic hepatitis C and in healthy subjects Transfusion 41(9): 1130-1135
Telfer, P.T.; Whitby, K.; Grant, P.; Garson, J.A.; Hoffbrand, A.V.; Wonke, B. 1996: Combination therapy with interferon alpha and ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients Blood 88(10 Suppl 1 Part 1-2): 527A
De Montalembert, M.; Lefrère, J.J.; Micheau, M.; Girot, R. 1994: Comparison of calculated and observed residual risks of transfusion-transmitted hepatitis C virus infection in multiply transfused patients. French Study Group on Thalassaemia Transfusion 34(8): 737-738
Beeby, P.J.; Spencer, J.D.; Cossart, Y.E. 2001: Risk of hepatitis C virus infection in multiply transfused premature neonates Journal of Paediatrics and Child Health 37(3): 244-246
Poovorawan, Y.; Theamboonlers, A.; Chongsrisawat, V.; Seksarn, P.; Jarvis, L.; Simmonds, P. 1998: High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia Journal of Gastroenterology and Hepatology 13(3): 253-256
Bocşan, I.S.; Neamţu, A.; Rădulescu, A.; Rafiroiu, C.; Suteu, O.; Pascu, O.; Vlăduţiu, D.; Neamţu, S.; Cucuianu, A.; State, D. 1995: The markers of hepatitis B, C and D viral infection in multiply transfused patients Bacteriologia Virusologia Parazitologia Epidemiologia 40(2): 109-113
Antipa, C.; Popescu, A.; Teleguţă, M.; Ruţă, S.; Cernescu, C.; Târdei, G.; Copelovici, Y.; Stoian, M.; Tivgă, N.; Hoinărescu, M. 1993: A seroprevalence study of the hepatitis C virus among multiply transfused patients Revue Roumaine de Virologie 44(1-2): 9-15
Baumgartner, J.D.; Glauser, M.P.; Burgo-Black, A.L.; Black, R.D.; Pyndiah, N.; Chiolero, R. 1982: Severe cytomegalovirus infection in multiply transfused, splenectomized, trauma patients Lancet 2(8289): 63-66
Jaggarao, N.S.V.; Grainger, R.; Heber, M.; Vincent, R.; Chamberlain, D.A.; Aronson, A.L. 1982: Use of An Automated External Defibrillator-Pacemaker by Ambulance Staff The Lancet 320(8289): 73-75
Brady, M.T.; Cuartas, J.F. 1992: HIV infection of multiply-transfused pediatric oncology patients in a low-prevalence area American Journal of Pediatric Hematology/Oncology 14(3): 233-235